REFERENCES
- Arnott WM, Biggs R, Gilchrist AR, et al: Assessment of short-term anticoagulant administration after cardiac infarction. Br Med 1: 335, 1969
- Wright IS, Marple CD, Beck DF: Myocardial Infarction—Report of the Committee on Anticoagulants of the American Heart Association. New York, Grune & Stratton Inc, 1954
- Harvald B, Hilden T, Lund E: Long-term anticoagulant therapy after myocardial infarction. Lancet 2: 626, 1962
- Seaman AJ, Griswold HE, Reaume RB, et al: Long- term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 281: 115, 1969
- Pickering G, Arnott WM, Biggs R, et al: An assessment of long-term anticoagulant administration after cardiac infarction. Br Med J 2: 837, 1964
- Ebert RV, Borden CW, Hipp HR, et al: Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration Cooperative Study. JAMA 207: 2263, 1969
- Kuhn PR, Van Ness LA, Jones RJ, et al: Long-term anticoagulant therapy after acute myocardial infarction. A retrospective study based upon a nine-year experience at the University of Chicago. Arch Intern Med 108: 884, 1961
- Wood P: Acute and subacute coronary insufficiency. Br Med J 5242: 1779, 1961
- Yeh TJ, Anabtawi IN, Cornett VE, et al: Influence of rhythm and anticoagulation upon the incidence of embolization associated with Starr-Edwards prostheses. Circulation 35: Suppl 1: 77, 1967
- Starr A: Mitral valve replacement with ball valve prostheses. Br Heart J 33: Suppl: 47, 1971
- Eskeland G, Solheim K, Skjörten F: Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures. A controlled clinical trial. Acta Chir Scand 131: 16, 1966
- Salzman EW, Harris WH, DeSanctis RW: Anticoagulation for prevention of thromboembolism following fractures of the hip. N Eng J Med 275: 122, 1966
- Salzman EW, Harris WH, DeSanctis RW: Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med 284: 1287, 1971
- Browse NL, Hall JH: Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet 2: 718, 1969
- Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. N Engl J Med 287: 999–1005, 1972
- Douglas AS: Current Status of Anticoagulant Treatment. In Poller L (Editor): Recent Advances in Blood Coagulation. London, J & A Churchill Ltd, 1969, p 107